Synergism of three-drug combinations of sanguinarine and other plant secondary metabolites with digitonin and doxorubicin in multi-drug resistant cancer cells

被引:81
作者
Eid, Safaa Yehia [1 ]
El-Readi, Mahmoud Zaki [1 ,2 ]
Wink, Michael [1 ]
机构
[1] Heidelberg Univ, Inst Pharm & Mol Biotechnol, D-69120 Heidelberg, Germany
[2] Al Azhar Univ, Fac Pharm, Dept Biochem, Assiut 71524, Egypt
关键词
Digitonin; Terpenoids; Alkaloids; Synergy; Doxorubicin; Reversal agent; Three-drug combination; LEUKEMIA-CELLS; ALKALOID EMETINE; DRUG-COMBINATION; MOLECULAR-MODES; TUMOR-CELLS; P-GP; APOPTOSIS;
D O I
10.1016/j.phymed.2012.08.010
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
We determined the ability of some phytochemicals, including alkaloids (glaucine, harmine, and sanguinarine), phenolics (EGCG and thymol), and terpenoids (menthol, aromadendrene, beta-sitosterol-O-glucoside, and beta-carotene), alone or in combination with the saponin digitonin to reverse the relative multi-drug resistance of Caco-2 and CEM/ADR5000 cells to the chemotherapeutical agent doxorubicin. The IC50 of doxorubicin in Caco-2 and CEM/ADR5000 was 4.22 and 44.08 mu M, respectively. Combination of non-toxic concentrations of individual secondary metabolite with doxorubicin synergistically sensitized Caco-2 and CEM/ADR5000 cells, and significantly enhanced the cytotoxicity of doxorubicin. Furthermore, three-drug combinations (secondary metabolite + digitonin + doxorubicin) were even more powerful. The best synergist was the benzophenanthridine alkaloid sanguinarine. It reduced the IC50 value of doxorubicin 17.58-fold in two-drug combinations (sanguinarine + doxorubicin) and even 35.17-fold in three-drug combinations (sanguinarine + digitonin + doxorubicin) in Caco-2 cells. Thus synergistic drug combinations offer the possibility to enhance doxorubicin efficacy in chemotherapy. (C) 2012 Elsevier GmbH. All rights reserved.
引用
收藏
页码:1288 / 1297
页数:10
相关论文
共 37 条
[1]   The saponin-mediated enhanced uptake of targeted saporin-based drugs is strongly dependent on the saponin structure [J].
Bachran, C ;
Sutherland, M ;
Heisler, I ;
Hebestreit, P ;
Melzig, MF ;
Fuchs, H .
EXPERIMENTAL BIOLOGY AND MEDICINE, 2006, 231 (04) :412-420
[2]   DNA-binding affinities and sequence selectivity of quaternary benzophenanthridine alkaloids sanguinarine, chelerythrine, and nitidine [J].
Bai, Li-Ping ;
Zhao, Zhong-Zhen ;
Cai, Zongwei ;
Jiang, Zhi-Hong .
BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (16) :5439-5445
[3]   Upregulation of multi drug resistance genes in doxorubicin resistant human acute myelogeneous leukemia cells and reversal of the resistance [J].
Baran, Yusuf ;
Guer, Bala ;
Kaya, Pelin ;
Ural, Ali Ugur ;
Avcu, Ferit ;
Guenduez, Ufuk .
HEMATOLOGY, 2007, 12 (06) :511-517
[4]  
BERENBAUM MC, 1989, PHARMACOL REV, V41, P93
[5]  
Cai Hong-Bing, 2002, Di Yi Jun Yi Da Xue Xue Bao, V22, P1112
[6]   Apoptosis induced by dioscin in Hela cells [J].
Cai, J ;
Liu, MJ ;
Wang, Z ;
Ju, Y .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2002, 25 (02) :193-196
[7]   β-Carboline alkaloids:: Biochemical and pharmacological functions [J].
Cao, Rihui ;
Peng, Wenlie ;
Wang, Zihou ;
Xu, Anlong .
CURRENT MEDICINAL CHEMISTRY, 2007, 14 (04) :479-500
[8]  
Chou J., 1988, Pharmacologist, V30, pA231
[9]   QUANTITATIVE-ANALYSIS OF DOSE-EFFECT RELATIONSHIPS - THE COMBINED EFFECTS OF MULTIPLE-DRUGS OR ENZYME-INHIBITORS [J].
CHOU, TC ;
TALALAY, P .
ADVANCES IN ENZYME REGULATION, 1984, 22 :27-55
[10]   Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies [J].
Chou, Ting-Chao .
PHARMACOLOGICAL REVIEWS, 2006, 58 (03) :621-681